David Dalmau

13.9k total citations
58 papers, 1.4k citations indexed

About

David Dalmau is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, David Dalmau has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Infectious Diseases, 37 papers in Virology and 17 papers in Emergency Medicine. Recurrent topics in David Dalmau's work include HIV Research and Treatment (37 papers), HIV/AIDS Research and Interventions (35 papers) and HIV/AIDS drug development and treatment (24 papers). David Dalmau is often cited by papers focused on HIV Research and Treatment (37 papers), HIV/AIDS Research and Interventions (35 papers) and HIV/AIDS drug development and treatment (24 papers). David Dalmau collaborates with scholars based in Spain, United States and Switzerland. David Dalmau's co-authors include Hernando Knobel, Peré Domingo, Ferrán Segura, Esteban Ribera, Enric Pedrol, Daniel Podzamczer, José M. Gatell, Bonaventura Clotet, Josep M. Llibre and Cristóbal Richart and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Cancer.

In The Last Decade

David Dalmau

58 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Dalmau Spain 21 970 774 333 329 127 58 1.4k
José Antonio Iribarren Spain 20 1.1k 1.1× 731 0.9× 312 0.9× 593 1.8× 281 2.2× 84 1.5k
Mathias Bruyand France 19 655 0.7× 278 0.4× 337 1.0× 283 0.9× 61 0.5× 35 1.1k
N Vetter Austria 18 624 0.6× 514 0.7× 190 0.6× 435 1.3× 74 0.6× 42 1.4k
Stephen Raffanti United States 25 1.2k 1.2× 711 0.9× 673 2.0× 508 1.5× 114 0.9× 58 1.9k
Michelle Jones United States 16 649 0.7× 515 0.7× 86 0.3× 422 1.3× 118 0.9× 23 1.3k
Alice Baruch United States 11 1.1k 1.1× 451 0.6× 71 0.2× 488 1.5× 56 0.4× 13 1.5k
Isabelle Ravaux France 17 613 0.6× 329 0.4× 215 0.6× 420 1.3× 201 1.6× 48 1.1k
Jody Lawrence United States 17 886 0.9× 736 1.0× 98 0.3× 212 0.6× 126 1.0× 34 1.2k
Winai Ratanasuwan Thailand 16 808 0.8× 594 0.8× 144 0.4× 257 0.8× 73 0.6× 38 957
Jaime E. Hernández United States 15 721 0.7× 531 0.7× 472 1.4× 262 0.8× 29 0.2× 38 1.1k

Countries citing papers authored by David Dalmau

Since Specialization
Citations

This map shows the geographic impact of David Dalmau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dalmau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dalmau more than expected).

Fields of papers citing papers by David Dalmau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Dalmau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dalmau. The network helps show where David Dalmau may publish in the future.

Co-authorship network of co-authors of David Dalmau

This figure shows the co-authorship network connecting the top 25 collaborators of David Dalmau. A scholar is included among the top collaborators of David Dalmau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Dalmau. David Dalmau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Restrepo, Clara, Mónica Gutiérrez‐Rivas, Yolanda M. Pacheco, et al.. (2019). Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression. PLoS ONE. 14(3). e0214421–e0214421. 9 indexed citations
2.
Rosado‐Sánchez, Isaac, Laura Tarancón‐Díez, Santiago Moreno, et al.. (2017). Increased frequencies of Th17 cells and IL17a-producing regulatory T-cells preceding the immunodiscordant response to antiretroviral treatment. Journal of Infection. 76(1). 86–92. 8 indexed citations
3.
4.
Sanmartí, Montserrat, Laura Ibáñez, Dolors Badenes, et al.. (2014). HIV-associated neurocognitive disorders. PubMed. 2(1). 2–2. 74 indexed citations
5.
Pou, Christian, Marc Noguera-Julián, Susana Pérez-Álvarez, et al.. (2014). Improved Prediction of Salvage Antiretroviral Therapy Outcomes Using Ultrasensitive HIV-1 Drug Resistance Testing. Clinical Infectious Diseases. 59(4). 578–588. 28 indexed citations
6.
Ibáñez, Laura, Ángeles Jaén, Mireia Cairó, et al.. (2014). HIV-Infection, Atherosclerosis and the Inflammatory Pathway: Candidate Gene Study in a Spanish HIV-Infected Population. PLoS ONE. 9(11). e112279–e112279. 4 indexed citations
7.
Baker, Jason V., Kathleen E. Brummel‐Ziedins, Jacqueline Neuhaus, et al.. (2013). HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation. Journal of the American Heart Association. 2(4). e000264–e000264. 59 indexed citations
8.
Hernando, Víctoria, Santiago Pérez Cachafeiro, Charlotte Lewden, et al.. (2012). All-cause and liver-related mortality in HIV positive subjects compared to the general population: Differences by HCV co-infection. Journal of Hepatology. 57(4). 743–751. 88 indexed citations
9.
Ferreyra, Cecilia, Oliver Yun, Samoel Khamadi, et al.. (2012). Evaluation of Clinical and Immunological Markers for Predicting Virological Failure in a HIV/AIDS Treatment Cohort in Busia, Kenya. PLoS ONE. 7(11). e49834–e49834. 44 indexed citations
10.
Codoñer, Francisco M., Christian Pou, Alexander Thielen, et al.. (2011). Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated HIV-1-Infected Subjects. PLoS ONE. 6(5). e19461–e19461. 44 indexed citations
11.
Giménez, Núria, et al.. (2009). Perspectiva de los profesionales sobre la investigación biomédica. Revista de Calidad Asistencial. 24(6). 245–255. 6 indexed citations
12.
Imaz, Arkaitz, Vicenç Falcó, María Luz Pintos Peñaranda, et al.. (2009). Impact of prior pneumococcal vaccination on clinical outcomes in HIV‐infected adult patients hospitalized with invasive pneumococcal disease. HIV Medicine. 10(6). 356–363. 14 indexed citations
13.
Peñaranda, María Luz Pintos, Vicenç Falcó, Antoni Payeras, et al.. (2007). Effectiveness of Polysaccharide Pneumococcal Vaccine in HIV-Infected Patients: a Case-Control Study. Clinical Infectious Diseases. 45(7). e82–e87. 47 indexed citations
14.
Bonjoch, Anna, Roger Paredes, Peré Domingo, et al.. (2006). Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients. AIDS Research and Human Retroviruses. 22(4). 321–329. 28 indexed citations
15.
Vidal, Francesc, Joaquim Peraire, Peré Domingo, et al.. (2005). Lack of Association of SDF-1 3′A Variant Allele With Long-Term Nonprogressive HIV-1 Infection Is Extended Beyond 16 Years. JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3). 276–279. 15 indexed citations
16.
Dalmau, David, Thomas Klimkait, & Amalio Telenti. (2005). Resistance to New Anti-HIV Agents: Problems in the Pathway of Drug Registration. Antiviral Therapy. 10(7). 867–872. 1 indexed citations
17.
Vidal, Francesc, Joaquim Peraire, Peré Domingo, et al.. (2005). Polymorphism of RANTES Chemokine Gene Promoter Is Not Associated With Long-Term Nonprogressive HIV-1 Infection of More Than 16 Years. JAIDS Journal of Acquired Immune Deficiency Syndromes. 41(1). 17–22. 17 indexed citations
18.
Knobel, Hernando, José M. Miró, Beatriz Mahíllo, et al.. (2004). Failure of Cetirizine to Prevent Nevirapine-Associated Rash. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(2). 1276–1281. 14 indexed citations
19.
Gómez, Lucía, Javier Garau, Cristina Estrada, et al.. (2003). Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin‐resistant Escherichia coli. Cancer. 97(2). 419–424. 50 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Antonio Iribarren Breakdown of academic impact, for papers by Mathias Bruyand Breakdown of academic impact, for papers by N Vetter Breakdown of academic impact, for papers by Stephen Raffanti Breakdown of academic impact, for papers by Michelle Jones Breakdown of academic impact, for papers by Alice Baruch Breakdown of academic impact, for papers by Isabelle Ravaux Breakdown of academic impact, for papers by Jody Lawrence Breakdown of academic impact, for papers by Winai Ratanasuwan Breakdown of academic impact, for papers by Jaime E. Hernández
Rankless by CCL
2026